Boston Scientific (Germany) Performance
| BSX Stock | EUR 86.50 0.50 0.58% |
On a scale of 0 to 100, Boston Scientific holds a performance score of 15. The firm shows a Beta (market volatility) of 0.5, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Boston Scientific's returns are expected to increase less than the market. However, during the bear market, the loss of holding Boston Scientific is expected to be smaller as well. Please check Boston Scientific's value at risk, expected short fall, and the relationship between the treynor ratio and downside variance , to make a quick decision on whether Boston Scientific's price patterns will revert.
Risk-Adjusted Performance
15 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Boston Scientific are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Boston Scientific reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 2.2 B |
Boston |
Boston Scientific Relative Risk vs. Return Landscape
If you would invest 7,100 in Boston Scientific on August 25, 2024 and sell it today you would earn a total of 1,550 from holding Boston Scientific or generate 21.83% return on investment over 90 days. Boston Scientific is currently producing 0.3174% returns and takes up 1.6302% volatility of returns over 90 trading days. Put another way, 14% of traded stocks are less volatile than Boston, and 94% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Boston Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Boston Scientific's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Boston Scientific, and traders can use it to determine the average amount a Boston Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1947
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BSX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.63 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.32 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average Boston Scientific is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Boston Scientific by adding it to a well-diversified portfolio.
Boston Scientific Fundamentals Growth
Boston Stock prices reflect investors' perceptions of the future prospects and financial health of Boston Scientific, and Boston Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Boston Stock performance.
| Return On Equity | 0.0408 | |||
| Return On Asset | 0.0393 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 72.27 B | |||
| Shares Outstanding | 1.43 B | |||
| Price To Earning | 317.20 X | |||
| Price To Book | 3.80 X | |||
| Price To Sales | 4.91 X | |||
| Revenue | 12.68 B | |||
| EBITDA | 2.75 B | |||
| Cash And Equivalents | 2.68 B | |||
| Cash Per Share | 1.88 X | |||
| Total Debt | 8.91 B | |||
| Debt To Equity | 0.59 % | |||
| Book Value Per Share | 12.26 X | |||
| Cash Flow From Operations | 1.53 B | |||
| Earnings Per Share | 0.42 X | |||
| Total Asset | 32.47 B | |||
About Boston Scientific Performance
By analyzing Boston Scientific's fundamental ratios, stakeholders can gain valuable insights into Boston Scientific's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Boston Scientific has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Boston Scientific has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts. BOSTON SCIENTIFIC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 38000 people.Things to note about Boston Scientific performance evaluation
Checking the ongoing alerts about Boston Scientific for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Boston Scientific help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 94.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Boston Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Boston Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Boston Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Boston Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Boston Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Boston Scientific's stock. These opinions can provide insight into Boston Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Boston Stock analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |